Sep 3 – 5, 2024
Switzerland
Europe/Zurich timezone

161Tb a promising radionuclide for early TRT: absorbed doses compared to 177Lu in micrometastases, cell clusters, and single tumour cells

Not scheduled
20m
Paul Scherrer Institut (Switzerland)

Paul Scherrer Institut

Switzerland

Forschungsstrasse 111 5232 Villigen

Speaker

Dr Elif Hindié ((CHU-Bordeaux)

Presentation materials